SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 433.40
arrow_upward
+1.12%(+4.80) 1D
Oct 7, 5:29:38 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 426.40
High
SEKÂ 434.80
Low
SEKÂ 426.40
Mkt. cap
152.74B
Avg. vol.
265.52K
Volume
201.87K
P/E ratio
115.76
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 426.40
High
SEKÂ 434.80
Low
SEKÂ 426.40
Mkt. cap
152.74B
Avg. vol.
265.52K
Volume
201.87K
P/E ratio
115.76
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
TradingView
·
1 hour ago
S&P 500 And Nasdaq 100 Slip From Record Highs Amid Pressure From Soaring Treasury Yields — SPCX, AMD, NVDA, MRVL In Focus
The Motley Fool
·
1 hour ago
The S&P 500 Just Reached a New Record. Here’s What History Says About Buying Stocks Now.
StoneX
·
7 hours ago
Dow Jones Forecast: Caution Persists Ahead of the Fed Minutes
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)